Ribociclib
From Proteopedia
| ||||||||||||
Ribociclib, sold under the brand name Kisqali, is a medication used for the treatment of certain kinds of breast cancer. Ribociclib inhibits the enzymes cyclin-dependent kinase 4 (CDK4) and cyclin-dependent kinase 6 (CDK6).
| ||||||||||||
This page was last modified 11:45, 30 October 2023.